2-[2-(Isothiourea)ethyl]-1H-benzo[de]isoquinoline-1,3(2H)-dione

ID: ALA1806659

PubChem CID: 53375909

Max Phase: Preclinical

Molecular Formula: C15H13N3O2S

Molecular Weight: 299.36

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N=C(N)SCCN1C(=O)c2cccc3cccc(c23)C1=O

Standard InChI:  InChI=1S/C15H13N3O2S/c16-15(17)21-8-7-18-13(19)10-5-1-3-9-4-2-6-11(12(9)10)14(18)20/h1-6H,7-8H2,(H3,16,17)

Standard InChI Key:  VNGWUTAIEDNBDZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    3.9774   -3.6038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9763   -4.4312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6892   -3.1912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6902   -4.8418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6886   -5.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4036   -6.0812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1215   -5.6651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4046   -3.6002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4034   -4.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1202   -4.8484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8428   -4.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8440   -3.6023    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1226   -3.1825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1226   -2.3575    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5560   -4.8498    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5594   -3.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2729   -3.6058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9883   -3.1951    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.7017   -3.6093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4171   -3.1986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6997   -4.4343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  4  1  0
  4  5  2  0
  8 13  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  5  6  1  0
 13 14  2  0
  8  3  2  0
 11 15  2  0
  6  7  2  0
 12 16  1  0
  7 10  1  0
 16 17  1  0
  8  9  1  0
 17 18  1  0
  3  1  1  0
 18 19  1  0
  1  2  2  0
 19 20  1  0
  9  4  1  0
 19 21  2  0
M  END

Associated Targets(Human)

UACC-903 (393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 299.36Molecular Weight (Monoisotopic): 299.0728AlogP: 2.06#Rotatable Bonds: 3
Polar Surface Area: 87.25Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.57CX LogP: 1.89CX LogD: -0.46
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.52Np Likeness Score: -0.73

References

1. Sk UH, Prakasha Gowda AS, Crampsie MA, Yun JK, Spratt TE, Amin S, Sharma AK..  (2011)  Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics.,  46  (8): [PMID:21609852] [10.1016/j.ejmech.2011.04.058]

Source